Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeniPhys is a regenerative medicine company developing Collymer, a proprietary polymerized collagen technology designed to facilitate tissue restoration. The Collymer platform produces a highly purified, bioinstructive scaffold that mimics the natural extracellular matrix, allowing for seamless integration with host tissues without triggering a foreign body response. The company's initial focus is on soft tissue reconstruction, including applications in breast surgery, wound healing, and surgical reinforcement. By providing a customizable material that can be engineered into various formats, GeniPhys aims to improve clinical outcomes over existing synthetic and animal-derived products. The technology originated from research at Purdue University and is currently moving toward clinical evaluation and regulatory submission.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeniPhys.